Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA approves Can-Fite's IND application for phase I study of CF-102 for liver cancer

Jan. 11, 2008

Nektar initiates phase II clinical program for PEG-Irinotecan in colorectal cancer

Jan. 11, 2008

ZymoGenetics initiates phase II trial of IL-21 with Nexavar for renal cell cancer

Jan. 10, 2008

Novel anticancer agents revealed in patent literature

Jan. 10, 2008

Coronado initiates phase I trial of fourth-generation doxorubicin analogue

Jan. 9, 2008

Exelixis initiates phase I/II trial of XL-184 for non-small cell lung cancer

Jan. 9, 2008

Allos initiates phase IIb study of PDX in patients with non-small cell lung cancer

Jan. 9, 2008

Recent patents impart new therapeutic agents for cancer

Jan. 9, 2008

Callisto restructures license agreement with Genzyme for atiprimod for carcinoid cancer

Jan. 8, 2008

Orphan drug designation granted for non-radiolabeled TM-601

Jan. 8, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...